| Literature DB >> 11139151 |
Abstract
Hepatitis C is a disease with varying rates of progression. The role of hepatitis B virus (HBV) as a cofactor in the development of hepatitis C virus (HCV)-related cirrhosis and hepatocellular carcinoma (HCC) has been suggested and the use of HBV vaccine in all HCV-infected patients has been advocated. This review presents the implications of HBV and HCV coinfection and addresses the issues of HBV vaccine immunogenicity and safety in patients with chronic HCV infection.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11139151 DOI: 10.1007/s150100070002
Source DB: PubMed Journal: Infection ISSN: 0300-8126 Impact factor: 3.553